CLEAR: (CLozapine in EARly psychosis) A Multi-Centre, Randomised Controlled trial of Clozapine for Young People with Treatment Resistant Psychosis in Real World Settings

Medicine & Life Sciences

1. Clozapine 100%
2. Psychotic Disorders 79%
3. Antipsychotic Agents 77%
4. Schizophrenia 69%
5. Randomized Controlled Trials 57%
6. Cost-Benefit Analysis 14%
7. Therapeutics 13%
8. Biomarkers 11%
9. Quality of Life 10%
10. Pharmacopoeias 10%
11. Safety 9%
12. Treatment Adherence and Compliance 9%
13. Child 7%
14. Magnetic Resonance Imaging 5%